Literature DB >> 16156789

A client-binding site of Cdc37.

Kazuya Terasawa1, Yasufumi Minami.   

Abstract

The molecular chaperone Hsp90 is distinct from Hsp70 and chaperonin in that client proteins are apparently restricted to a subset of proteins categorized as cellular signaling molecules. Among these, many specific protein kinases require the assistance of Hsp90 and its co-chaperone Cdc37/p50 for their biogenesis. A series of Cdc37 deletion mutants revealed that all mutants capable of binding Raf-1 possess amino acid residues between 181 and 200. The 20-residue region is sufficient and, in particular, a five-residue segment (residue 191-195) is essential for binding to Raf-1. These five residues are present in one alpha helix (residues 184-199) in the middle of Cdc37, which is unexpectedly nested within the Hsp90-interacting domain of Cdc37, which was recently determined by crystallography, but does not seem to contribute to direct contact with Hsp90. Furthermore, an N-terminally truncated mutant of Cdc37 composed of residues 181-378 was shown to bind the N-terminal portion of Raf-1 (subdomains I-IV). This mutant can bind not only other Hsp90 client protein kinases, Akt1, Aurora B and Cdk4, but also Cdc2 and Cdk2, which to date have not been shown to physically interact with Cdc37. These results suggest that a region of Cdc37 other than the client-binding site may be responsible for discriminating client protein kinases from others.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156789     DOI: 10.1111/j.1742-4658.2005.04884.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

1.  Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.

Authors:  Asuka Ota; Jun Zhang; Peipei Ping; Jiahuai Han; Yibin Wang
Journal:  Circ Res       Date:  2010-03-18       Impact factor: 17.367

2.  Structure of an Hsp90-Cdc37-Cdk4 complex.

Authors:  Cara K Vaughan; Ulrich Gohlke; Frank Sobott; Valerie M Good; Maruf M U Ali; Chrisostomos Prodromou; Carol V Robinson; Helen R Saibil; Laurence H Pearl
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

3.  Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases.

Authors:  Kazuya Terasawa; Katsuhiko Yoshimatsu; Shun-Ichiro Iemura; Tohru Natsume; Keiji Tanaka; Yasufumi Minami
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

4.  Cdc37 regulates Ryk signaling by stabilizing the cleaved Ryk intracellular domain.

Authors:  Jungmook Lyu; Robin L Wesselschmidt; Wange Lu
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

5.  Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.

Authors:  Dimitra Keramisanou; Adam Aboalroub; Ziming Zhang; Wenjun Liu; Devon Marshall; Andrea Diviney; Randy W Larsen; Ralf Landgraf; Ioannis Gelis
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

6.  Hsp90-Sgt1 and Skp1 target human Mis12 complexes to ensure efficient formation of kinetochore-microtubule binding sites.

Authors:  Alexander E Davies; Kenneth B Kaplan
Journal:  J Cell Biol       Date:  2010-04-19       Impact factor: 10.539

7.  Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice.

Authors:  E Ikebe; A Kawaguchi; K Tezuka; S Taguchi; S Hirose; T Matsumoto; T Mitsui; K Senba; A Nishizono; M Hori; H Hasegawa; Y Yamada; T Ueno; Y Tanaka; H Sawa; W Hall; Y Minami; K T Jeang; M Ogata; K Morishita; H Hasegawa; J Fujisawa; H Iha
Journal:  Blood Cancer J       Date:  2013-08-16       Impact factor: 11.037

8.  ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system.

Authors:  Sigrun Polier; Rahul S Samant; Paul A Clarke; Paul Workman; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Nat Chem Biol       Date:  2013-03-17       Impact factor: 15.040

9.  Structural bioinformatics and protein docking analysis of the molecular chaperone-kinase interactions: towards allosteric inhibition of protein kinases by targeting the hsp90-cdc37 chaperone machinery.

Authors:  Nathan Lawless; Kristin Blacklock; Elizabeth Berrigan; Gennady Verkhivker
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-11

10.  Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Authors:  J R Smith; E de Billy; S Hobbs; M Powers; C Prodromou; L Pearl; P A Clarke; P Workman
Journal:  Oncogene       Date:  2013-12-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.